“A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital”. 2022. Asian Journal of Pharmaceutical and Health Sciences 12 (4): 2729-38. https://doi.org/10.5530/ezagjy22.